Yu Li (李钰)

Yu Li (李钰)

Harvard University - Cambridge / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 6058089
person_outline Yu Li (李钰)'s MOST POPULAR ARTICLES
1-) Development of a RSK inhibitor as a novel therapy for triple-negative breast cancerKA Ludwik, JP Campbell, M Li, Y Li, ZM Sandusky, L Pasic, ME Sowder, ...Molecular cancer therapeutics 15 (11), 2598-2608, 2016672016
2-) Synthesis and structure–activity relationship study of 5a-carbasugar analogues of SL0101M Li, Y Li, RM Mrozowski, ZM Sandusky, M Shan, X Song, B Wu, Q Zhang, ...ACS Medicinal Chemistry Letters 6 (1), 95-99, 2015332015
3-) Stereoselective synthesis and evaluation of C6 ″-Substituted 5a-Carbasugar analogues of SL0101 as inhibitors of RSK1/2M Li, Y Li, KA Ludwik, ZM Sandusky, DA Lannigan, GA O’DohertyOrganic letters 19 (9), 2410-2413, 2017302017
4-) RSK2 maintains adult estrogen homeostasis by inhibiting ERK1/2-mediated degradation of estrogen receptor alphaKA Ludwik, ZM Sandusky, KM Stauffer, Y Li, KL Boyd, GA O’Doherty, ...Cell reports 32 (3), 2020142020
5-) Regioselective Synthesis of a C-4′′ Carbamate, C-6′′ n-Pr Substituted Cyclitol Analogue of SL0101Y Li, ZM Sandusky, R Vemula, Q Zhang, B Wu, S Fukuda, M Li, ...Organic Letters 22 (4), 1448-1452, 2020132020